Zobrazeno 1 - 10
of 27
pro vyhledávání: '"Jean-Pierre Charmes"'
Autor:
Claire Guy, Marie-Josèphe Jean-Pastor, Isabelle Ingrand, Marie-Laure Laroche, Marie-Christine Perault-Pochat, Fati Nourhashemi, Annie-Pierre Jonville-Béra, Jean-Pierre Charmes, Isabelle Merlet-Chicoine, Louis Merle, Ghada Miremont-Salamé, Anne Castot-Villepelet, Geneviève Durrieu, Carmen Kreft-Jais, Valérie Gras
Publikováno v:
Pharmacoepidemiology and Drug Safety. 22:952-960
Purpose To assess the prevalence of adverse drug reactions (ADRs) occurring in patients with Alzheimer’s disease (AD) or other dementia in France. Methods A cross-sectional multicentre study was conducted by the French network of the 31 regional ph
Publikováno v:
Actualités Pharmaceutiques. 50:24-29
Publikováno v:
La Revue de Médecine Interne. 30:592-601
Drug induced adverse effects are frequently encountered in geriatrics. Their occurrence can be limited by an adapted prescription. Potentially inappropriate medications are drugs with an unfavourable benefit to risk ratio when other safer or more eff
Publikováno v:
European Journal of Clinical Pharmacology. 63:725-731
To evaluate drug-related problems in the elderly, various lists of potentially inappropriate medications have been published in North America. Unfortunately, these lists are hardly applicable in France. The purpose of this study was to establish a li
Publikováno v:
Pharmacotherapy. 26:1041-1046
Publikováno v:
Drugs & Aging. 23:49-59
Potentially inappropriate medication use is a major safety issue in the elderly and may cause a substantial proportion of drug-related hospital admissions. Hospitalisation could result in a change in the quantity and type of drugs, but its effect on
Publikováno v:
La Revue de Médecine Interne. 24:436-442
Resume Propos. – La paraoxonase 1 est une esterase serique et tissulaire ubiquitaire dans l’organisme humain. Elle est connue en toxicologie pour jouer un role protecteur contre les intoxications par les composes organophosphores mais semble auss
Publikováno v:
Annals of the New York Academy of Sciences. 977:239-244
An esterase, paraoxonase 1 (PON1), protects against organophosphate neurotoxicity and decreases lipoprotein oxidation. Two polymorphisms of PON1 [192 (R or Q) and 55 (M or L)] exist and are associated with coronary artery disease. We have previously
Autor:
Hanta Lacroix-Ramiandrisoa, Jean Debord, Louis Merle, Jean-Pierre Charmes, Thierry Dantoine, Laurence Bourzeix
Publikováno v:
Annals of the New York Academy of Sciences. 977:96-101
Paraoxonase 1 (PON1), an A-esterase with peroxidase-like activity present on the surface of HDL, decreases the peroxidation of LDL. Serum PON1 activity (PON1a) decreases with aging and in disorders associated with a high risk of adverse cardiovascula
Publikováno v:
Peritoneal Dialysis International: Journal of the International Society for Peritoneal Dialysis. 22:528-531